Literature DB >> 19959807

Individualization at the heart of comparative effectiveness research: the time for i-CER has come.

Anirban Basu1.   

Abstract

Mesh：

Year:  2009        PMID： 19959807     DOI： 10.1177/0272989X09351586

Source DB:  PubMed          Journal:  Med Decis Making        ISSN： 0272-989X            Impact factor:   2.583


× No keyword cloud information.
  11 in total

1.  HETEROGENEITY IN TREATMENT EFFECT AND COMPARATIVE EFFECTIVENESS RESEARCH.

Authors:  Zhehui Luo
Journal:  China Health Rev       Date:  2011-10

2.  Estimating Decision-Relevant Comparative Effects Using Instrumental Variables.

Authors:  Anirban Basu
Journal:  Stat Biosci       Date:  2011-09

3.  A CTSA agenda to advance methods for comparative effectiveness research.

Authors:  Mark Helfand; Sean Tunis; Evelyn P Whitlock; Stephen G Pauker; Anirban Basu; Jon Chilingerian; Frank E Harrell; David O Meltzer; Victor M Montori; Donald S Shepard; David M Kent
Journal:  Clin Transl Sci       Date:  2011-06       Impact factor: 4.689

4.  ESTIMATING PERSON-CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTS.

Authors:  Anirban Basu
Journal:  J Appl Econ (Chichester Engl)       Date:  2014 June/July

5.  Patient-centered or 'central' patient: Raising the veil of ignorance over randomization.

Authors:  Anirban Basu
Journal:  Stat Med       Date:  2012-11-10       Impact factor: 2.373

6.  The relationship of antidepressant prescribing concentration to treatment duration and cost.

Authors:  Dominic Hodgkin; Elizabeth L Merrick; Deirdre Hiatt
Journal:  J Ment Health Policy Econ       Date:  2012-03

7.  Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care.

Authors:  Anirban Basu
Journal:  J Health Econ       Date:  2011-04-23       Impact factor: 3.883

8.  The impact of comparative effectiveness research on health and health care spending.

Authors:  Anirban Basu; Anupam B Jena; Tomas J Philipson
Journal:  J Health Econ       Date:  2011-06-01       Impact factor: 3.883

9.  A Framework for Prioritizing Research Investments in Precision Medicine.

Authors:  Anirban Basu; Josh J Carlson; David L Veenstra
Journal:  Med Decis Making       Date:  2015-10-26       Impact factor: 2.583

10.  Evaluating the clinical impact of a genomic classifier in prostate cancer using individualized decision analysis.

Authors:  Jennifer Mason Lobo; Adam P Dicker; Christine Buerki; Elai Daviconi; R Jeffrey Karnes; Robert B Jenkins; Nirav Patel; Robert B Den; Timothy N Showalter
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.